Premier Alternatives

Vivodyne

San Francisco, CA · Founded 2020 · Privately Held (backing)

Developer of a platform designed to provide a more accurate and efficient method for preclinical drug testing. Vivodyne is based in San Francisco, CA and was founded in 2020. It was valued at $174 million at its later-stage round in May 2025, the last priced event on record. It has raised $79.6 million across 1 recorded round; the latest was a $77.7 million later-stage round in Feb 2025.

PMV mark · valuation
$174.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$79.6M
Last round
Later Stage VC
Feb 2025

Vivodyne key facts

as of Oct 2026
  • Developer of a platform designed to provide a more accurate and efficient method for preclinical drug testing.
  • Vivodyne is valued at approximately $174.0M as of Oct 2026, set at its later-stage round, May 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $79.6M across 1 recorded rounds; the latest was Later Stage VC ($77.7M) in Feb 2025.
  • Notable investors include Khosla Ventures, MBX Capital, Lingotto, Fortius Ventures, Bison Ventures — 12 tracked in total.
  • Vivodyne has filed 1 Form D with the SEC, most recently Jun 2025 ($77.7M sold to 18 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$174.0M

Valued at $174.0M at its later-stage round, May 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Vivodyne with a free account
  • ·The complete investor list: 12 names
  • ·Watch Vivodyne: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Vivodyne funding rounds

1 rounds
Feb 2025Later Stage VC$77.7MSEC filing▮
Full funding history →

Vivodyne valuation

Vivodyne was valued at $174 million at its later-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Vivodyne raised?

Vivodyne has raised $79.6 million across 1 recorded round since 2025. The largest was a $77.7 million later-stage round in Feb 2025.

Vivodyne has filed 1 Form D with the SEC, most recently in Jun 2025 ($77.7 million sold to 18 investors).

Vivodyne investors

12 investors are on record for Vivodyne, including Khosla Ventures, MBX Capital, Lingotto and Fortius Ventures. The later-stage round in Feb 2025 drew 18 investors.

About Vivodyne

Developer of a platform designed to provide a more accurate and efficient method for preclinical drug testing. The company's platform utilizes lab-grown human organ models, coupled with advanced robotic systems and sophisticated artificial intelligence, enabling pharmaceutical developers to obtain clinically predictive data, ultimately accelerating the creation of safe and more effective therapeutics.

Sector
Healthcare
HQ
San Francisco, CA, United States
Founded
2020
Employees
40
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.